1 Roda G,Chien NS,Kotze PG,et al.Crohn's disease.Nat Rev Dis Primers,2020,6:22. 2 何琼,李建栋.炎症性肠病流行病学研究进展.实用医学杂志,2019,35:2962-2966. 3 何瑶,李玥,谭蓓,等.炎症性肠病妊娠期管理的专家共识意见.协和医学杂志,2019,10:465-475. 4 Kim MA,Kim YH,Chun J,et al.The influence of disease activity on pregnancy outcomes in women with inflammatory bowel disease:a systematic review and meta-analysis.J Crohns Colitis,2021,15:719-732. 5 Laube R,Paramsothy S,Leong RW.Review of pregnancy in Crohn's disease and ulcerative colitis.Therap Adv Gastroenterol,2021,14:1088199218. 6 Ran Z,Wu K,Matsuoka K,et al.Asian organization for crohn's and colitis and asia pacific association of gastroenterology practice recommendations for medical management and monitoring of inflammatory bowel disease in Asia.J Gastroenterol Hepatol,2021,36:637-645. 7 Reinisch W,Colombel JF,Sandborn WJ,et al.Factors associated with short- and long-term outcomes of therapy for Crohn's disease.Clin Gastroenterol Hepatol,2015,13:539-547. 8 Ferreiro-Iglesias R,Barreiro-de AM,Otero SM,et al.Fecal calprotectin as predictor of relapse in patients with inflammatory bowel disease under maintenance infliximab therapy.J Clin Gastroenterol,2016,50:147-151. 9 Flanagan E,Wright EK,Begun J,et al.Monitoring inflammatory bowel disease in pregnancy using gastrointestinal ultrasonography.J Crohns Colitis,2020,14:1405-1412. 10 Syversen SW,Goll GL,Jørgensen KK,et al.Effect of therapeutic drug monitoring vs standard therapy during infliximab induction on disease remission in patients with chronic immune-mediated inflammatory diseases:a randomized clinical trial.JAMA,2021,325:1744-1754. 11 Guerrero VD,Kane SV.Biologics and pregnancy:a clinician's guide to the management of IBD in pregnant women.Expert Rev Gastroenterol Hepatol,2021,15:633-641. 12 Foulon A,Dupas JL,Sabbagh C,et al.Defining the most appropriate delivery mode in women with inflammatory bowel disease:a systematic review.Inflamm Bowel Dis,2017,23:712-720. 13 Grouin A,Brochard C,Siproudhis L,et al.Perianal Crohn's disease results in fewer pregnancies but is not exacerbated by vaginal delivery.Dig Liver Dis,2015,47:1021-1026. 14 Truta B.Therapeutic drug monitoring in inflammatory bowel disease:At the right time in the right place.World J Gastroenterol,2022,28:1380-1383. 15 Park SH,Kim HJ,Lee CK,et al.Safety and optimal timing of BCG vaccination in infants born to mothers receiving anti-TNF therapy for inflammatory bowel disease.J Crohns Colitis,2020,14:1780-1784.
